About this trial
The goal of this observational study is to evaluate the performance of UCH-L1 and GFAP combined in patients with a mild traumatic brain injury. The main question :
• Does the combination of UCH-L1 and GFAP can exclude brain injuries detected with CT scan in the first twelve hours after a mild traumatic brain injury?
Participants will do the exams planed in routine care and :
* during the expected blood sampling an additional blood sample will be done, * seven days after the discharge a call will be done by the investigator.
Eligibility criteria
Qualifiers
Traumatic brain injury defined by
Impact on the skull or the face AND OR
Acceleration / deceleration
Glasgow Coma Scal 13, 14 or 15
Disqualifiers
Person not affiliated or not benefiting from a health insurance scheme.
Person under judicial protection.
Person with restrictions of freedom or subject to Articles L.3212-1 and L.3213-1, and not included in Article L.1122-8 of the French CSP
Blood collection time > 12 hours
Trial design
Treatments tested in this trial
- UCH-L1 GFAP
Treatment groups
Sponsors and collaborators
Centre Hospitalier Princesse Grace
Lead sponsor
BioMérieux
Collaborator
Assistance Publique - Hôpitaux de Paris
Collaborator
University Hospital, Clermont-Ferrand
Collaborator
Hospices Civils de Lyon
Collaborator
Poitiers University Hospital
Collaborator
University Hospital, Angers
Collaborator
Centre Hospitalier Universitaire de Nīmes
Collaborator
Centre Hospitalier Universitaire de Nice
Collaborator
Nantes University Hospital
Collaborator
University Hospital, Montpellier
Collaborator
Centre Hospitalier Universitaire Dijon
Collaborator
University Hospital, Grenoble
Collaborator
Fondation Hôpital Saint-Joseph
Collaborator
CHU de Tours
Collaborator